Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
Apollo Telehealth has established more than 700 centers, in 7 states
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Subscribe To Our Newsletter & Stay Updated
